| Title |
Transarterial (chemo)embolisation for unresectable hepatocellular carcinoma
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2011
|
| DOI | 10.1002/14651858.cd004787.pub2 |
| Pubmed ID | |
| Authors |
Roberto S Oliveri, Jørn Wetterslev, Christian Gluud |
| Abstract |
Hepatocellular carcinoma (HCC) results in more than 600,000 deaths per year. Transarterial embolisation (TAE) and transarterial chemoembolisation (TACE) have become standard loco-regional treatments for unresectable HCC. |
X Demographics
The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 188 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | 1% |
| France | 2 | 1% |
| Germany | 1 | <1% |
| Switzerland | 1 | <1% |
| Spain | 1 | <1% |
| Canada | 1 | <1% |
| Unknown | 180 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 13% |
| Other | 17 | 9% |
| Student > Master | 16 | 9% |
| Student > Ph. D. Student | 15 | 8% |
| Student > Bachelor | 15 | 8% |
| Other | 39 | 21% |
| Unknown | 62 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 86 | 46% |
| Nursing and Health Professions | 7 | 4% |
| Agricultural and Biological Sciences | 7 | 4% |
| Biochemistry, Genetics and Molecular Biology | 6 | 3% |
| Psychology | 5 | 3% |
| Other | 12 | 6% |
| Unknown | 65 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 October 2012.
All research outputs
#15,253,344
of 22,681,577 outputs
Outputs from Cochrane database of systematic reviews
#10,766
of 12,298 outputs
Outputs of similar age
#84,756
of 108,059 outputs
Outputs of similar age from Cochrane database of systematic reviews
#82
of 94 outputs
Altmetric has tracked 22,681,577 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 12,298 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,059 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 94 others from the same source and published within six weeks on either side of this one. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.